| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |